With the Supreme Court's grant last week of certiorari in the Myriad Genetics case (to answer the question whether human genes isolated from the body are patentable), and the antipathy of the court, perceived by many, to patents generally, we are reminded to consider what may be the underpinnings of such antipathy.
Criticism Attacks Patents as Impediments to Innovation
The Legal Intelligencer
December 5, 2012
This article requires premium access
This article requires premium access to The Legal Intelligencer. Please sign in or subscribe to read the full text.